Advanced Filters
noise
Found 64,920 clinical trials
N Nuray Akyüz, Assoc Prof

The Effect of Preoperative Stoma Simulation on Anxiety and Postoperative Adaptation

The majority of patients (60-70%) develop high levels of anxiety before surgery. Surgical patients may experience feelings of anxiety due to insufficient information and counseling before surgery and potential changes in the body caused by surgery. Fears include (but are not limited to) not waking up from anesthesia, not being …

18 - 65 years of age All Phase N/A

Evaluation of PEEK and BruxZir as Esthetic Space Maintainers in Children

Compare two band and loop space maintainers made from two tooth colored materials; Polyetherethherketone (PEEK) and monolithic Zirconia (BruxZir) as regards to: Clinical performance of space maintainers in terms of frequency of debonding or fracture of the appliance and health of adjacent gingiva during a one-year follow up. Wear of …

6 - 11 years of age All Phase N/A

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

This Study is a single arm, open label, multicenter phase III clinical trial to evaluate the safety and efficacy of VC004 in patients with locally advanced/metastatic solid tumors.

12 years of age All Phase 3
D Dr Amman Ullah Nazir, PhD*

Effects of IASTM and Kinesiotaping in Plantar Fascitis

The Objective of the study is to compare the effectiveness of Instrumental Assisted Soft Tissue Mobilization (IASTM) and Kinesio taping for improving foot functional status and Quality of Life (QOL) in patients with Plantar Fasciitis. The study will be randomized controlled Trial including 2 experimental groups and 19 participants in …

20 - 40 years of age All Phase N/A
D Doaa Osman, Assis.prof

Impact of Virtual Reality Model for Pelvic Floor Anatomy on Users' Educational Level and Experience

The purpose of the study is to evaluate the impact of virtual reality (VR) model for pelvic floor anatomy on users' educational level and experience.

19 - 45 years of age All Phase N/A
C Chris Kapp, MD

The SEQUENCE Trial: Evaluating Diagnostic Yield of Robotic-assisted Bronchoscopy When Staging EBUS is Performed First or Second in the Same Procedure

Robotic-assisted bronchoscopy (RaB) has afforded proceduralists the ability to accurately reach the periphery of the lung for biopsy of pulmonary nodules1. This has paved the way for patients to undergo both biopsy of a peripheral nodule and a staging linear endobronchial ultrasound (EBUS) in the same anesthesia event, promoting quicker …

18 years of age All Phase N/A
S Shujun Yang, Professor

A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors

This is a phase I/II study to evaluate the safety and tolerability, DLT(Dose limited toxicity), MTD(Maximum tolerated dose), and RP2D(Recommended phase II dose) of WJB001 capsules in patients with advanced solid tumors, including dose escalation phase, dose expansion phase and cohort expansion phase.The study includes screening, treatment and follow-up periods. …

18 years of age All Phase 1/2
s sherihan R. ahmed, MD

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

Along with the current clinical trial, the efficacy and safety of a 20 mg rivaroxaban administered within 24 hours of randomization after having first-ever cerebral venous thrombosis compared to apixaban 5mg Bid were assessed through rate of recurrent VTE, mRS, rate of venous recanalization, HIT score, MoCA test, and central …

18 - 75 years of age All Phase 3
D Daniel O'Brien, A/Prof

Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).

The goal of this interventional clinical trial is to determine if treatment with 4 weeks of telacebac (T) will completely heal lesions in participants with Buruli ulcer (BU) by 52 weeks after treatment initiation, without relapse and/or surgery. Males and females age 18 and older will be included. • Participants …

18 years of age All Phase 2
Z Zelei Dai

HF50 in HER-2 Positive and Low-expression Advanced Solid Tumors

This is an open-label, single-arm, non-randomized, single-center, dose-escalation study designed to evaluate the safety and tolerability of HF50 in patients with HER-2 positive and HER-2 low-expression advanced solid tumors. The primary objectives are to assess the safety, tolerability, and determine the maximum tolerated dose (MTD) and/or recommended Phase II dose …

18 - 75 years of age All Phase N/A

Simplify language using AI